Historical Development and Strategic Growth
LSB MedTech Holding Group Ltd, originally founded in the Netherlands, has since relocated its headquarters to the United Arab Emirates while maintaining multiple subsidiaries across Europe.

Our Expertise
At LSB MedTech, we specialize in the development, patenting and production of advanced medical technologies powered by Artificial Intelligence (AI) and data science. Our solutions are designed to support clinical decision-making, enhance operational efficiency and systematically improve patient outcomes. Our technologies are integrated into Clinical Decision Support Systems (CDSS), where real-time data analysis enables accurate, context-sensitive recommendations in complex healthcare environments. Additionally, we employ Natural Language Processing (NLP) to interpret unstructured clinical data, along with predictive AI models that facilitate risk stratification and early detection of clinical deterioration. These innovations empower healthcare professionals to make informed decisions and contribute to more personalized, proactive, and high-quality care delivery.

Strategic Milestones
Until mid-2018, LSB MedTech, together with Maastricht University, was a co-owner and investor in Vitak Group Ltd. Vitak Group was the world’s largest MGP CRO laboratory. Within this organization, a specialized medical technology division was established, focusing on innovations in vascular elasticity monitoring and anticoagulants. Additionally, the pharmaceutical division specialized in vitamin K antagonists and vascular calcification research.

Mid-2018 – In collaboration with several academic institutions, LSB MedTech established its own CRO laboratory. This facility provided specialized CRO services to pharmaceutical companies and the food industry, contributing to both clinical and applied research within these sectors.

Mid-2021 – LSB MedTech expanded its activities to include innovation consultancy services in the field of patient care for nursing homes and hospitals. This initiative aimed at developing and implementing innovative healthcare solutions with the primary goal of enhancing patients’ quality of life.

Mid-2023 – The CRO laboratory activities were acquired by a Japanese CRO company, after which LSB MedTech fully transitioned its focus to medical innovation technology, patient care technology, innovation consultancy, and IP valorization. These operations are conducted from the company’s headquarters in the United Arab Emirates and partially in the Netherlands.